InvestorsHub Logo
Followers 2
Posts 339
Boards Moderated 0
Alias Born 02/03/2010

Re: staccani post# 37632

Sunday, 07/19/2015 6:59:10 AM

Sunday, July 19, 2015 6:59:10 AM

Post# of 699228
Sure, but the article certainly hinted to a late stage phaseIII trial for cancer immunotherapy. And seeming as that's the most likely to see approval first, I think it makes sense to assume L. Also, the company, while blinded still has a far better idea of whats going on in the trial than we do and right now, they are preparing for launch.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News